The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to SARS-CoV-2
Related studies linked through entity extraction aliases.
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2
- Status
- COMPLETED
- Phase
- PHASE3
Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50
- Status
- TERMINATED
- Phase
- PHASE3
The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects
- Status
- UNKNOWN
- Phase
- NA
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE2
PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effectiveness of Moderna COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- N/A
A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster
- Status
- COMPLETED
- Phase
- PHASE1
Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19
- Status
- COMPLETED
- Phase
- N/A
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- N/A
Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19
- Status
- COMPLETED
- Phase
- N/A
Changes of Optical Quality During the Peak of the Covid-19 Pandemic
- Status
- COMPLETED
- Phase
- N/A
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)
- Status
- UNKNOWN
- Phase
- PHASE1